Top Markets
#1 Black Phoenix Black Phoenix +21,471.53%
#2 Nesa Nesa +742.33%
#3 Kinesis Silver Kinesis Silver +54.95%
#4 Derive Derive +28.36%
#5 BNB Attestation Service BNB Attestation Service +24.81%
#6 QuantixAI QuantixAI +24.69%
#7 EXOD EXOD +22.78%
#8 Zylo Ecosystem Zylo Ecosystem +15.96%
#9 Pons Pons +15.89%
#10 Biconomy Biconomy +15.66%
Coin of the day
Black Phoenix Black Phoenix
設定
言語
日本
通貨
USD
テーマ
Inari Medical, Inc. Inari Medical, Inc.

Inari Medical, Inc.

NARI
株式のランク #3844
Inari Medical, Inc. is a medical technology firm focused on creating,... Inari Medical, Inc. is a medical technology firm focused on creating, producing, promoting, and distributing devices for the minimally invasive management of venous conditions within the United States. Their product portfolio includes ClotTriever, a mechanical thrombectomy solution designed to extract significant clots from major blood vessels, specifically targeting deep vein thrombosis. Another key offering is FlowTriever, a substantial catheter-based aspiration and mechanical thrombectomy system, which addresses pulmonary embolism. The company also provides FlowSaver; FlowStasis, a large-bore suture retention device to manage venous access points; and FlowTriever 2, an enhanced version with a new disk design for efficiently capturing wall-adherent clots and reducing procedure time. Founded in 2011, the company was initially known as Inceptus Newco1 Inc. before rebranding as Inari Medical, Inc. in September 2013. Its corporate headquarters are located in Irvine, California.
株価
$79.97
最終同期: 2025-02-19
時価総額
$4.57B
変化（1日）
0.00%
変化（1年）
0.00%
国
US
取引 Inari Medical, Inc. (NARI)

カテゴリー

Healthcare
Inari Medical, Inc.（NARI）のP/E比率
August 2026 時点のP/E比率 TTM -2.78K
Inari Medical, Inc. の最新の財務報告および株価によると、現在の P/E (TTM) は -2.78K です。2022 年末時点での P/E は -114.75 でした。
Inari Medical, Inc. の P/E 比率の履歴（2018 〜 2026）
各年末のP/E比率
年 P/E比率 変化
2026 (TTM) -2.78K 23.26%
2023 -2.25K 1,863.22%
2022 -114.75 -124.83%
2021 462.06 127.86%
2020 202.79 -118.88%
2019 -1.07K 470.60%
2018 -188.21 0.00%
類似企業や競合他社のP/E比率
企業 P/E比率 P/E比率の差 国
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 35.77 -101.29%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 34.86 -101.26%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 21.39 -100.77%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 20.90 -100.75%
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
 - -
DE
P/E比率の読み方

株価収益率（P/E Ratio）は、企業の株価と1株あたり利益の関係を示します。
低いが正のP/Eは、現在の評価額に対して高い利益を上げている企業を示し、割安と見なされる可能性があります。高い負の（0に近い）P/Eは、損失が大きいことを示します。

P/Eが30を超えるか、負である企業は一般に「成長株」と見なされ、投資家は将来的な成長または黒字化を期待しています。

10未満の正のP/Eを持つ企業は一般に「割安株」と見なされ、既に収益性が高いが成長の余地は小さいと見なされます。